151 related articles for article (PubMed ID: 38431880)
21. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
Hsu CH; Peng KL; Kang ML; Chen YR; Yang YC; Tsai CH; Chu CS; Jeng YM; Chen YT; Lin FM; Huang HD; Lu YY; Teng YC; Lin ST; Lin RK; Tang FM; Lee SB; Hsu HM; Yu JC; Hsiao PW; Juan LJ
Cell Rep; 2012 Sep; 2(3):568-79. PubMed ID: 22999938
[TBL] [Abstract][Full Text] [Related]
22. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
[TBL] [Abstract][Full Text] [Related]
23. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
Yu M; Li D; Cao W; Chen X; Du W
Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
[TBL] [Abstract][Full Text] [Related]
24. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
25. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
26. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
[TBL] [Abstract][Full Text] [Related]
27. miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma.
He B; Chen J; Song W; Bai Y
Genomics; 2021 May; 113(3):1469-1481. PubMed ID: 33667646
[TBL] [Abstract][Full Text] [Related]
28. Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition.
Gao J; Liu R; Feng D; Huang W; Huo M; Zhang J; Leng S; Yang Y; Yang T; Yin X; Teng X; Yu H; Yuan B; Wang Y
Cell Death Differ; 2021 Sep; 28(9):2818-2836. PubMed ID: 33953349
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis.
Sang Y; Cheng C; Tang XF; Zhang MF; Lv XB
Asian Pac J Cancer Prev; 2015; 16(3):1197-200. PubMed ID: 25735355
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1.
Hu B; Shi G; Li Q; Li W; Zhou H
J Cell Biochem; 2019 Apr; 120(4):6330-6338. PubMed ID: 30362292
[TBL] [Abstract][Full Text] [Related]
31. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
Guo H; Zhu H; Zhang J; Wan B; Shen Z
J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
[TBL] [Abstract][Full Text] [Related]
32. FAM20C could be targeted by TET1 to promote odontoblastic differentiation potential of human dental pulp cells.
Li Q; Yi B; Feng Z; Meng R; Tian C; Xu Q
Cell Prolif; 2018 Apr; 51(2):e12426. PubMed ID: 29277934
[TBL] [Abstract][Full Text] [Related]
33. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer.
Good CR; Madzo J; Patel B; Maegawa S; Engel N; Jelinek J; Issa JJ
Nucleic Acids Res; 2017 Aug; 45(14):8269-8281. PubMed ID: 28531272
[TBL] [Abstract][Full Text] [Related]
34. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
Sun X; Zhu H; Cao R; Zhang J; Wang X
Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
[TBL] [Abstract][Full Text] [Related]
35. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑4284 promotes gastric cancer tumorigenicity by targeting ten-eleven translocation 1.
Li Y; Shen Z; Jiang H; Lai Z; Wang Z; Jiang K; Ye Y; Wang S
Mol Med Rep; 2018 May; 17(5):6569-6575. PubMed ID: 29512746
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
[TBL] [Abstract][Full Text] [Related]
39. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
[TBL] [Abstract][Full Text] [Related]
40. TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition.
Bamezai S; Demir D; Pulikkottil AJ; Ciccarone F; Fischbein E; Sinha A; Borga C; Te Kronnie G; Meyer LH; Mohr F; Götze M; Caiafa P; Debatin KM; Döhner K; Döhner H; González-Menéndez I; Quintanilla-Fend L; Herold T; Jeremias I; Feuring-Buske M; Buske C; Rawat VPS
Leukemia; 2021 Feb; 35(2):389-403. PubMed ID: 32409690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]